Home
Pharmaceuticals
Brain Related Drug Development
Technology & Pipeline
Lantibiotics
Vaccine Program
Science & Technology
News & Media
Press Releases
In The News
Careers
Presentations
Publications
Abstracts
Investors
Investor Relations
Overview
News / Events
Press Releases
Email Alerts
IR Calendar
Company Info
Profile
Presentations
Management Team
Contacts
FAQ
Financial Info
Financials
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
About
Overview
Management Team
Board of Directors
Scientific Advisors
Contact Us
Careers
Home
Investors
SEC Filings
All SEC Filings
Investors
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All SEC Filings
Filter Filings:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
144
25-NSE
3
4
4/A
424B3
424B4
424B5
5
5/A
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTAMX
CERTNYS
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
06/30/20
424B3
Prospectus filed pursuant to Rule 424(b)(3)
28
06/26/20
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
06/19/20
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
2
06/19/20
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
50
06/15/20
UPLOAD
SEC-generated letter
Related Documents
TEXT-EXTRACT
2
06/05/20
8-K
Current report filing
Related Documents
EX-10.3
5
05/29/20
S-3
Registration statement for specified transactions by certain issuers
Related Documents
EX-5.1
EX-23.1
EX-23.2
38
05/29/20
8-K/A
Current report filing
Related Documents
EX-23.1
EX-99.1
EX-99.2
22
05/15/20
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
6
05/15/20
3
Initial statement of beneficial ownership of securities
2
<< Previous
1...
23
24
25
26
27
28
29
30
31
32
...107
Next >>